DaVita Inc. Reports on Security Holder Vote

Ticker: DVA · Form: 8-K · Filed: 2025-06-09T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-vote, governance

Related Tickers: DVA

TL;DR

DaVita shareholders voted on something June 5th, 8-K filed June 9th.

AI Summary

DaVita Inc. filed an 8-K on June 9, 2025, reporting on a matter submitted to a vote of its security holders on June 5, 2025. The filing does not provide details on the specific vote or its outcome, but it is a required disclosure for such events.

Why It Matters

This filing indicates a formal decision-making process involving DaVita's shareholders, which could have implications for the company's governance or strategic direction.

Risk Assessment

Risk Level: low — The filing is a procedural disclosure of a shareholder vote without immediate financial or operational impact details.

Key Players & Entities

FAQ

What specific matter was submitted for a vote by DaVita Inc. security holders on June 5, 2025?

The filing does not specify the exact matter that was submitted for a vote by DaVita Inc. security holders on June 5, 2025.

What was the outcome of the vote held on June 5, 2025?

The 8-K filing does not disclose the outcome of the vote that took place on June 5, 2025.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on June 9, 2025.

What is DaVita Inc.'s principal executive office address?

DaVita Inc.'s principal executive office is located at 2000 16th Street, Denver, CO 80202.

What is the Commission File Number for DaVita Inc.?

The Commission File Number for DaVita Inc. is 1-14106.

From the Filing

0000927066-25-000107.txt : 20250609 0000927066-25-000107.hdr.sgml : 20250609 20250609163113 ACCESSION NUMBER: 0000927066-25-000107 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250605 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250609 DATE AS OF CHANGE: 20250609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 251034553 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva-20250605.htm 8-K dva-20250605 0000927066 false 0000927066 2025-06-05 2025-06-05   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): June 5, 2025     DAVITA INC. (Exact name of registrant as specified in its charter)     DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   2000 16th Street Denver, CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)   ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class:   Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value   DVA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐     Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07.    Submission of Matters to a Vote of Security Holders. On June 5, 2025, DaVita Inc. (the “Company”) held its virtual 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Represented virtually or by proxy at the Annual Meeting were 69,548,287 shares of the Company's common stock, or approximately 90% of its outstanding shares of common stock as of April 9, 2025, the record date of the An

View on Read The Filing